Press release
Diabetic Neuropathy Market Size USD 6,298.1 MN By 2031 Key Pharma Players Investing | Japan Updates - 2025
Diabetic Neuropathy Market
Latest Japan News on Diabetic Neuropathy (2025)
In April 2025, a Japan-based pharmaceutical company, Ono Pharmaceutical, announced a Phase 2 clinical trial for a novel drug targeting painful diabetic peripheral neuropathy (DPN). The trial is focused on evaluating the safety and efficacy of a selective sodium channel blocker, showing promise in reducing nerve pain without central nervous system side effects.
Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/diabetic-neuropathy-market?kb
Diabetic Neuropathy Market Overview
Diabetic neuropathy refers to nerve damage caused by diabetes, often leading to pain, numbness, and weakness, primarily in the legs and feet. The market includes diagnostics, treatment options like pain relief medications, and ongoing R&D to manage or prevent nerve complications in diabetic patients.
Research Methodology:
The global Diabetic Neuropathy Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.
Segment Covered in the Diabetic Neuropathy Market:
By Type: Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy.
By Drug Class: Anti-Depressant, Anti-Convulsant, Opioids, NSAIDs, Others.
By Distribution Channel: Hospitals and Clinics Pharmacy, Retail Pharmacy and Stores, Online Pharmacy.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/diabetic-neuropathy-market?kb
List of the Key Players in the Diabetic Neuropathy Market:
Depomed pharma, Eli Lilly, Daiichi Sankyo, Teva Pharmaceutical Industries Ltd., Xenoport, Grünenthal, Johnson and Johnson, Pfizer, GlaxoSmithKline and Boehringer Ingelheim among others.
Industry Development:
In March 2022, Daiichi Sankyo Company Limited, a prominent global healthcare innovator, received regulatory approval in Japan to broaden the indications for its Tarlige Tablets (mirogabalin besilate). Initially approved for treating peripheral neuropathic pain, the new approval extends its use to cover a wider range of neuropathic pain conditions-enabling more patients to benefit from this effective analgesic therapy.
In July 2022, Teva Pharmaceutical Industries Ltd. and NeuroFront Therapeutics (Hong Kong) Limited announced a strategic collaboration through an exclusive licensing and commercialization agreement. This partnership aims to advance the development of NRD.E1, a novel non-opioid investigational drug originally developed by Novaremed. NRD.E1 is being explored as a treatment for diabetic neuropathic pain and other neuropathic pain disorders, representing a major step toward offering safer, non-opioid alternatives for chronic pain management.
Regional Analysis for Diabetic Neuropathy Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Diabetic Neuropathy market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Diabetic Neuropathy industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Diabetic Neuropathy market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Neuropathy Market Size USD 6,298.1 MN By 2031 Key Pharma Players Investing | Japan Updates - 2025 here
News-ID: 4073040 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Grant Management Software Market Set to Reach USD 3.3 Billion by 2030, Fueled by …
The Global Grant Management Software Market, valued at US$ 1.5 billion in 2022, is projected to grow at a CAGR of 10.3% to reach US$ 3.3 billion by 2030. The market is experiencing robust growth driven by strategic industry consolidation, the acceleration of digital transformation across public and private sectors, and the mainstream integration of artificial intelligence to automate complex workflows and enhance decision-making.
Get a Free Sample PDF Of This…
Ceramic Adhesives Market Set for Steady Growth to USD 11.2 Billion by 2030, Fuel …
The Global Ceramic Adhesives Market reached US$ 7.5 billion in 2022 and is expected to reach US$ 11.2 billion by 2030, growing at a CAGR of 5.1% during the forecast period 2023-2030. This sustained growth is driven primarily by the rapid expansion of the construction industry worldwide, which demands durable and reliable bonding solutions for tile installation, flooring, and wall cladding. The shift towards high-performance adhesives with superior strength and…
Automotive Elastomers Market Poised for Steady Growth to USD 51.4 Billion by 203 …
The Global Automotive Elastomers Market reached US$ 32.5 billion in 2022 and is expected to reach US$ 51.4 billion by 2030, growing at a CAGR of 5.3% during the forecast period 2023-2030. This sustained growth is propelled by the global automotive industry's relentless pursuit of vehicle lightweighting to improve fuel efficiency and meet emissions regulations, the rising adoption of electric vehicles (EVs) requiring specialized components, and the superior performance of…
Plant-Based Ice Cream Market Scoops Up Growth to Reach USD 1.83 Billion by 2032, …
The Global Plant-Based Ice Cream Market reached US$ 1.05 billion in 2024 and is projected to reach US$ 1.83 billion by 2032, growing at a CAGR of 7.21% during the forecast period 2025-2032. This robust growth is propelled by a significant increase in the vegan population, heightened consumer health consciousness regarding lactose intolerance and cholesterol, and a powerful shift in dietary preferences toward sustainable, dairy-free alternatives, with North America leading…
More Releases for Neuropathy
Small-Fiber Neuropathy (SFN) Market Poised for Rapid Growth as Demand for Neurop …
The global Small-Fiber Neuropathy (SFN) market is witnessing robust growth, driven by rising diabetic and idiopathic neuropathy prevalence, improved diagnostics, and growing demand for effective therapies. The market is expected to show steady long-term expansion through 2034, signaling strong opportunities for healthcare providers, pharma companies, and investors.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72073
1. Keyword Definition - Small-Fiber Neuropathy (SFN)
Small-Fiber Neuropathy (SFN) is a neurological disorder caused by damage…
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding
WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to…
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market
Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,…
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market?
The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The…
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market?
The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses…
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810
This latest report researches the industry structure,…
